ESGCT 2026 Preview: Gene and Cell Therapy Trends
ESGCT 2026 at a glance ESGCT 2026 will spotlight emerging cell and gene therapy…
Hematology Today—May 25, 2026
This week’s Hematology update highlights regulatory approvals, reimbursement…
In Vivo CAR-T: Stress-Testing the Lilly–Kelonia Deal with AI-Powered Wargaming
Produced with LucidWargames, part of the LucidQuest ecosystem. AI-enabled…
Lucid Diligence Brief: Eli Lilly acquires Kelonia for up to $7 billion in cash
Lucid Diligence Brief: Eli Lilly acquires Kelonia for up to $7 billion in cash…
Cell and Gene Therapy Today—February 12, 2026
This week's Cell and Gene Therapy update highlights key regulatory actions,…
Lucid Diligence Brief: Vyriad $25M Series B to take in-vivo CAR-T into clinic
Lucid Diligence Brief: Vyriad $25M Series B to take in-vivo CAR-T into clinic…
Lucid Diligence Brief: Bristol Myers Squibb's acquisition of Orbital Therapeutics
Lucid Diligence Brief: Bristol Myers Squibb's acquisition of Orbital…
Latest Immunology News - Sept 25th to Oct 8th 2025
Watch Our Video Summary Capturing Top Immunology News from the Last Two Weeks…
Cell and Gene Therapy Weekly News - October 2nd 2025
Gene & Cell Therapy Update: eXmoor × Siam Bioscience Partnership, FDA Fast…
Immunology Weekly News - October 1st 2025
Immunology Update: EndoQuest Robotics, $1.8M NIH grant, BMS Patient Connect and…